Compounded tirzepatide usually costs $50 to $100 more than compounded semaglutide. At Mochi the gap is $30 — $60 for semaglutide against $90 for tirzepatide — which makes its tirzepatide the more interesting of the two prices.
$90 a month for compounded tirzepatide is materially below the market. Measured publishes $219, Eden $199, Fridays $198 and CoreAge Rx $129. Mochi is undercutting the nearest competitor by a third.
The $79 monthly membership closes much of that gap. At $169 all-in, Mochi sits above CoreAge Rx's $129-with-no-membership and below Eden's effective $298. The headline is exceptional; the total is competitive rather than category-leading.
Why the branded path matters more for tirzepatide
Tirzepatide's branded products — Mounjaro and Zepbound — are the ones with the largest trial weight reductions in this drug class. Mochi publishes Mounjaro at $499 a month, in the same grid as the $90 compounded line.
Publishing both prices side by side is unusual and useful: it lets you see exactly what the compounded discount is buying and costing. A provider that shows you a $409 monthly gap is being more straightforward than one that simply never mentions the approved product exists.
What it actually costs per year
Advertised prices in this category are usually medication only. Add the membership back in and the ranking changes. Pick a provider, or enter the quote you were given.
One-month semaglutide rate. Starting at $79/month equivalent requires a 12-month plan ($948 total); confirm payment and renewal terms.
- First month
- $139
- Every month after
- $139
- Total over 12 months
- $1,668
No membership on this plan, so every dollar goes to medication and care.
Figures are the providers' own published prices as of our last review of each. Promotional rates, multi-month prepayment and dose changes can all move these numbers — confirm at checkout.
What compounded tirzepatide actually is
Tirzepatide is the active ingredient in Mounjaro and Zepbound, both FDA-approved products from Eli Lilly. Unlike semaglutide, it acts on two receptors — GLP-1 and GIP — which is the basis for the larger average weight reductions seen in its trials. A compounded version is prepared by a pharmacy and is not FDA-approved or FDA-evaluated.
Compounded tirzepatide is consistently more expensive than compounded semaglutide, typically by $50 to $100 a month. That gap is real and reflects the raw material, so a provider pricing them identically is worth a question rather than a celebration.
Dosing usually starts at 2.5 mg weekly and escalates in 2.5 mg steps. As with semaglutide, dose-flat pricing is worth substantially more than a low starting price, because the starting dose is not the dose most people end up on.
Side effects mirror semaglutide's — predominantly gastrointestinal, worst after dose increases — though some patients report tirzepatide is better tolerated at equivalent efficacy. That is an individual matter and not something a telehealth intake form can predict for you.
Before you buy from anyone
- Get the total monthly cost in writing — medication plus any membership, not the headline figure.
- Ask whether the price changes as your dose increases. This is where most of the money is lost.
- Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
- Confirm what happens if you stop after one month, and whether there is an auto-rebill.
- Ask whether a refund is available if a provider declines to prescribe.
- Tell the prescriber every medication and supplement you take, including anything bought online.